ADMA Biologics Inc (ADMA) valuation · P/E 15, rev $510.2M
ADMA Biologics Inc (ADMA) P/E 15, rev $510.2M.
| Metric | Value |
|---|---|
| P/E | 15 |
| Market cap | $4.39B |
| Revenue | $510.2M |
| P/S | 8.6 |
ADMA valuation FAQ
What is ADMA's P/E ratio?
ADMA Biologics Inc (ADMA) trailing P/E is 15 on the latest cached fundamentals snapshot.
What is ADMA's market cap?
ADMA Biologics Inc (ADMA) market cap is $4.39B on the latest cached fundamentals snapshot.
What is ADMA's latest revenue?
Latest cached ADMA Biologics Inc (ADMA) revenue was $510.2M. Statements: https://lician.com/financials/adma
What is ADMA's price-to-sales ratio?
ADMA Biologics Inc (ADMA) price-to-sales (P/S) is 8.6, cached market cap $4.39B divided by revenue $510.2M.
How many ADMA valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for ADMA Biologics Inc (ADMA): P/E, Market cap, Revenue, and P/S.
Where is ADMA valuation listed?
Cached valuation multiples for ADMA Biologics Inc (ADMA) are listed at https://lician.com/valuation/adma.
Not investment advice. Cached rows, not a live tape.